{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:25:17Z","timestamp":1792409117844,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002024.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T00:00:00Z","timestamp":1462233600000}}],"reference-count":108,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002024.pub5","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T05:24:45Z","timestamp":1462253085000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Alpha<sub>2<\/sub>-adrenergic agonists for the management of opioid withdrawal"],"prefix":"10.1002","volume":"2016","author":[{"given":"Linda","family":"Gowing","sequence":"first","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Frome Road Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[{"name":"University of New South Wales; National Drug and Alcohol Research Centre; 36 King Street Randwick Sydney NSW Australia NSW 2025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ali","sequence":"additional","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Frome Road Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M","family":"White","sequence":"additional","affiliation":[{"name":"University of South Australia; School of Pharmacy and Medical Sciences; GPO Box 2471 Adelaide Australia SA 5001"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/09595238780000031","article-title":"A placebo controlled trial of clonidine in the outpatient management of heroin withdrawal","volume":"6","author":"Batey","year":"1987","journal-title":"Australian Drug and Alcohol Review"},{"issue":"1-2","key":"10.1002\/14651858.CD002024.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0376-8716(96)01289-6","article-title":"Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal","volume":"43","author":"Bearn","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"issue":"42","key":"10.1002\/14651858.CD002024.pub5-BIB0003|cit3","first-page":"991","article-title":"Clonidine in opiate withdrawal syndrome","volume":"103","author":"Benos","year":"1985","journal-title":"Fortschritte der Medizin"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1006\/phrs.1997.0170","article-title":"The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine","volume":"35","author":"Bertschy","year":"1997","journal-title":"Pharmacological Research"},{"issue":"1-2","key":"10.1002\/14651858.CD002024.pub5-BIB0005|cit5","first-page":"1","article-title":"Treatment of opiate withdrawal syndrome with nonnarcotic drugs in addicts undergoing voluntary detoxication. I. Effect of clonidine","volume":"65","author":"Bruno","year":"1979","journal-title":"Lavoro Neuropsichiatrico"},{"issue":"3","key":"10.1002\/14651858.CD002024.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/clpt.1985.182","article-title":"Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin","volume":"38","author":"Cam\u00ed","year":"1985","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD002024.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0376-8716(98)00040-4","article-title":"Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal","volume":"50","author":"Carnwath","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0740-5472(94)00077-8","article-title":"Clonidine and opiate receptor antagonists in the treatment of heroin addiction","volume":"12","author":"Gerra","year":"1995","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0740-5472(99)00050-1","article-title":"Rapid opiate detoxification in outpatient treatment: relationship with naltrexone compliance","volume":"18","author":"Gerra","year":"2000","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1002\/14651858.CD002024.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1360-0443.1988.tb00535.x","article-title":"Clonidine in heroin withdrawal syndrome: a controlled study in India","volume":"83","author":"Gupta","year":"1988","journal-title":"British Journal of Addiction"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0011|cit11","unstructured":"Howells C Allen S Gupta J Farrell M A double blind study comparing the efficacy of methadone and lofexidine in the treatment of opiate detoxification in prisoners at HMP Winchester Britannia Pharmaceuticals Ltd 1999"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0376-8716(02)00024-8","article-title":"Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone","volume":"67","author":"Howells","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0013|cit13","first-page":"10","article-title":"Rapid detoxification with clonidine for heroin addiction: a comparative study on its efficacy vs methadone","volume":"26","author":"Jiang","year":"1993","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0376-8716(96)01316-6","article-title":"Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital","volume":"44","author":"Kahn","year":"1997","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD002024.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archpsyc.1985.01790270081009","article-title":"Clonidine in outpatient detoxification from methadone maintenance","volume":"42","author":"Kleber","year":"1985","journal-title":"Archives of General Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD002024.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00952998509016845","article-title":"Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts","volume":"11","author":"Kosten","year":"1985","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0010-440X(84)90049-X","article-title":"Relationship of depression to clonidine detoxification of opiate addicts","volume":"25","author":"Kosten","year":"1984","journal-title":"Comprehensive Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00005053-198502000-00007","article-title":"Success and failure at outpatient opioid detoxification: evaluating the process of clonidine and methadone assisted withdrawal","volume":"173","author":"Rounsaville","year":"1985","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0019|cit19","first-page":"50","article-title":"Use of qigong therapy in the detoxification of heroin addicts","volume":"8","author":"Li","year":"2002","journal-title":"Alternative Therapies in Health and Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(97)00116-6","article-title":"Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal","volume":"48","author":"Lin","year":"1997","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0021|cit21","first-page":"169","article-title":"Comparative effectiveness of alpha-2 adrenergic agonists (clonidine and guanfacine) in the hospital detoxification of opiate addicts","volume":"94","author":"Muga","year":"1990","journal-title":"Medicina Clinica"},{"issue":"22","key":"10.1002\/14651858.CD002024.pub5-BIB0022|cit22","first-page":"1628","article-title":"Hab-o Shefa (an Iranian traditional medicine compound) in withdrawal syndrome and its effects in acute detoxification of opiates addict: a randomized, double blind, clinical trials","volume":"7","author":"Nazari","year":"2013","journal-title":"Journal of Medicinal Plant Research"},{"issue":"8","key":"10.1002\/14651858.CD002024.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1360-0443.1992.tb02001.x","article-title":"Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts","volume":"87","author":"Cami","year":"1992","journal-title":"British Journal of Addiction"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1360-0443.1990.tb00634.x","article-title":"Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial","volume":"85","author":"San","year":"1990","journal-title":"British Journal of Addiction"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1360-0443.1989.tb00554.x","article-title":"Success and failure at inpatient heroin detoxification","volume":"84","author":"San","year":"1989","journal-title":"British Journal of Addiction"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0740-5472(94)90100-7","article-title":"Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients","volume":"11","author":"San","year":"1994","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0027|cit27","unstructured":"Senay E Tennant FS Washton AM [Boehringer Ingelheim GmbH report number U85-0844] Boehringer Ingelheim Pty Ltd 1983"},{"issue":"15","key":"10.1002\/14651858.CD002024.pub5-BIB0028|cit28","first-page":"783","article-title":"Tizanidine in the treatment of acute withdrawal symptoms in heroin dependent patients","volume":"141","author":"Sos","year":"2000","journal-title":"Orvosi Hetilap"},{"issue":"3","key":"10.1002\/14651858.CD002024.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0376-8716(02)00325-3","article-title":"Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection","volume":"69","author":"Umbricht","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"17","key":"10.1002\/14651858.CD002024.pub5-BIB0030|cit30","first-page":"674","article-title":"Methadone, clonidine and levomepromazine in the treatment of opiate abstinence syndrome: double-blind clinical trial in heroin-addicted patients admitted to a general hospital for organic pathology","volume":"88","author":"Vilalta","year":"1987","journal-title":"Medicina Clinica"},{"issue":"9","key":"10.1002\/14651858.CD002024.pub5-BIB0032|cit31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1176\/ajp.137.9.1121","article-title":"Clonidine for opiate detoxification - outpatient clinical trials","volume":"137","author":"Washton","year":"1980","journal-title":"American Journal of Psychiatry"},{"issue":"8207","key":"10.1002\/14651858.CD002024.pub5-BIB0033|cit32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(80)92356-9","article-title":"Clonidine versus methadone for opiate detoxification","volume":"2","author":"Washton","year":"1980","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0034|cit33","article-title":"Clonidine vs methadone for opiate detoxification: double-blind outpatient trials","volume-title":"Problems of Drug Dependence, 1980. Proceedings of the 42nd Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc","author":"Washton","year":"1981"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0031|cit34","first-page":"233","article-title":"Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal","volume":"27","author":"Washton","year":"1979","journal-title":"NIDA Research Monograph"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.04.002","article-title":"A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal","volume":"97","author":"Yu","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/00952990802308122","article-title":"Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis","volume":"34","author":"Yu","year":"2008","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2710.2001.00325.x","article-title":"Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial","volume":"26","author":"Ahmadi-Abhari","year":"2001","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2710.2000.00295.x","article-title":"Double-blind randomised controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal","volume":"25","author":"Akhondzadeh","year":"2000","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/09595238580000071","article-title":"Outpatient detoxification in heroin users - a comparison of a hemineurin and a clonidine regime","volume":"4","author":"Batey","year":"1985","journal-title":"Australian Alcohol\/Drug Review"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0376-8716(98)00030-1","article-title":"Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification","volume":"50","author":"Bearn","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD002024.pub5-BIB0041|cit41","first-page":"295","article-title":"The effectiveness of combined naloxone\/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial","volume":"12","author":"Beswick","year":"2003","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/1355621031000069882","article-title":"Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments","volume":"8","author":"Beswick","year":"2003","journal-title":"Addiction Biology"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0043|cit43","unstructured":"Casey PR Tomiak RHH Clonidine in opiate withdrawal Boehringer Ingelheim Ltd 1988"},{"issue":"4","key":"10.1002\/14651858.CD002024.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajp.2010.08.005","article-title":"Tramadol versus clonidine in management of heroin withdrawal","volume":"3","author":"Chattopadhyay","year":"2010","journal-title":"Asian Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0376-8716(94)90093-0","article-title":"A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids","volume":"36","author":"Cheskin","year":"1994","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0046|cit46","first-page":"103","article-title":"The treatment of clonidine for opiate withdrawal symptoms","volume":"32","author":"Chuang","year":"1999","journal-title":"Chinese Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jsat.2010.08.007","article-title":"Outpatient versus inpatient opioid detoxification: a randomized controlled trial","volume":"40","author":"Day","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0740-5472(01)00178-7","article-title":"Lofexidine versus clonidine in rapid opiate detoxification","volume":"21","author":"Gerra","year":"2001","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1002\/14651858.CD002024.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1192\/bjp.165.3.370","article-title":"Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction","volume":"165","author":"Ghodse","year":"1994","journal-title":"British Journal of Psychiatry"},{"issue":"8090","key":"10.1002\/14651858.CD002024.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(78)92823-4","article-title":"Clonidine blocks acute opiate-withdrawal symptoms","volume":"2","author":"Gold","year":"1978","journal-title":"The Lancet"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/ajp.136.1.100","article-title":"Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal","volume":"136","author":"Gold","year":"1979","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002024.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1176\/ajp.137.3.375","article-title":"Effect of methadone dosage on clonidine detoxification efficacy","volume":"137","author":"Gold","year":"1980","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0053|cit53","first-page":"299","article-title":"Clinical utility of clonidine in opiate withdrawal: a study of 100 patients","volume":"71","author":"Gold","year":"1981","journal-title":"Progress in Clinical and Biological Research"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0054|cit54","first-page":"239","article-title":"Clonidine decreases opiate withdrawal-related anxiety: possible opiate noradrenergic interaction in anxiety and panic","volume":"1","author":"Gold","year":"1980","journal-title":"Substance and Alcohol Actions\/Misuse"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0376-8716(89)90077-X","article-title":"The detoxification of high dose heroin addicts in Pakistan","volume":"24","author":"Gossop","year":"1989","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1176\/ajp.148.5.627","article-title":"Comparison of Acetophen with clonidine for opiate withdrawal symptoms","volume":"148","author":"Hartmann","year":"1991","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0057|cit57","first-page":"109","article-title":"A new combined treatment for opioid detoxification: the association between dextropropoxyphene and guanfacine","volume":"22","author":"Huertas","year":"1995","journal-title":"Revista de Psiquiatria de la Facultad de Medicina de Barcelona"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0376-8716(94)90096-5","article-title":"Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine","volume":"36","author":"Janiri","year":"1994","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1002\/14651858.CD002024.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archpsyc.1985.01790340041006","article-title":"Clonidine in morphine withdrawal: differential effects on signs and symptoms","volume":"42","author":"Jasinski","year":"1985","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD002024.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1360-0443.2002.00196.x","article-title":"Nimodipine in opiate detoxification: a controlled trial","volume":"97","author":"Jimenez-Lerma","year":"2002","journal-title":"Addiction"},{"issue":"10","key":"10.1002\/14651858.CD002024.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3109\/10826089009058878","article-title":"Clonidine versus long and short term methadone aided withdrawal from opiates: an uncontrolled comparison","volume":"25","author":"Kasvikis","year":"1990","journal-title":"International Journal of the Addictions"},{"issue":"11","key":"10.1002\/14651858.CD002024.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00005053-199511000-00008","article-title":"Home-based inpatient treatment vs outpatient day clinic treatment: a preliminary report in opiate-dependent patients","volume":"183","author":"Lerner","year":"1995","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"4","key":"10.1002\/14651858.CD002024.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/JCP.0000000000000144","article-title":"A double-blind, placebo-controlled trial of dextromethorphan combined with clonidine in the treatment of heroin withdrawal","volume":"34","author":"Lin","year":"2014","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000259168","article-title":"Clonidine versus withdrawal using an opioid in in-patient opioid detoxification","volume":"3","author":"Malhotra","year":"1997","journal-title":"European Addiction Research"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2006.09.020","article-title":"In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine+naloxone, lofexidine+placebo, and methadone","volume":"88","author":"McCambridge","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02599882","article-title":"Primary care-based ambulatory opioid detoxification: the results of a clinical trial","volume":"10","author":"O'Connor","year":"1995","journal-title":"Journal of General Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/BF02599459","article-title":"Ambulatory opiate detoxification and primary care: a role for the primary care physician","volume":"7","author":"O'Connor","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD002024.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-127-7-199710010-00004","article-title":"Three methods of opioid detoxification in a primary care setting. A randomised trial","volume":"127","author":"O'Connor","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0069|cit69","first-page":"309","article-title":"Three methods of ambulatory opiate detoxification: preliminary results of a randomized clinical trial","volume":"132","author":"Shi","year":"1993","journal-title":"NIDA Research Monograph Series"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ADM.0b013e3181e518cc","article-title":"A nonopioid procedure for outpatient opioid detoxification","volume":"5","author":"Ockert","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0071|cit71","first-page":"99","article-title":"Dapiprazole compared with clonidine and a placebo in detoxification of opiate addicts","volume":"11","author":"Pini","year":"1991","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(90)93046-S","article-title":"Dapiprazole versus clonidine and versus placebo in detoxification of opiate addicts","volume":"183","author":"Pini","year":"1990","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0073|cit73","first-page":"368","article-title":"Very low-dose naltrexone versus placebo in alleviating withdrawal manifestation","volume":"52","author":"Rezaiyan","year":"2014","journal-title":"Clinical Toxicology"},{"issue":"3","key":"10.1002\/14651858.CD002024.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0376-8716(95)01159-8","article-title":"Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts","volume":"39","author":"Dawe","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1002\/14651858.CD002024.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1360-0443.1993.tb02146.x","article-title":"Does post-withdrawal cue exposure improve outcome in opiate addiction? A controlled trial","volume":"88","author":"Dawe","year":"1993","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/14651858.CD002024.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0306-4603(93)90065-H","article-title":"Can opiate addicts tell us about their relapse risk? Subjective predictors of clinical prognosis","volume":"18","author":"Powell","year":"1993","journal-title":"Addictive Behaviors"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1192\/bjp.171.4.335","article-title":"Type of hospital setting and treatment outcome with heroin addicts. Results from a randomised trial","volume":"171","author":"Strang","year":"1997","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002024.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0740-5472(93)90056-8","article-title":"Methadone combined with clonidine versus clonidine alone in opiate detoxification","volume":"10","author":"Wilson","year":"1993","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"393","key":"10.1002\/14651858.CD002024.pub5-BIB0079|cit79","first-page":"217","article-title":"Lofexidine based regimen for opiate addicts","volume":"45","author":"Wylie","year":"1995","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000018962","article-title":"The use of lofexidine by drug dependency units in the United Kingdom","volume":"5","author":"Akhurst","year":"1999","journal-title":"European Addiction Research"},{"issue":"9","key":"10.1002\/14651858.CD002024.pub5-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005031.pub2","article-title":"Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003409.pub4","article-title":"Methadone at tapered doses for the management of opioid withdrawal","author":"Amato","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(99)00063-0","article-title":"Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months","volume":"58","author":"Broers","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004580.pub2","article-title":"Inpatient versus other settings for detoxification for opioid dependence","author":"Day","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD002024.pub5-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1360-0443.1994.tb03745.x","article-title":"Opiate withdrawal","volume":"89","author":"Farrell","year":"1994","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/14651858.CD002024.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jama.1980.03300300021018","article-title":"Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment","volume":"243","author":"Gold","year":"1980","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.1981.tb12809.x","article-title":"The neurobiological implications of clonidine HCl","volume":"362","author":"Gold","year":"1989","journal-title":"Annals of the New York Academy of Science"},{"issue":"3","key":"10.1002\/14651858.CD002024.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0376-8716(88)90078-6","article-title":"Clonidine and the treatment of the opiate withdrawal syndrome","volume":"21","author":"Gossop","year":"1988","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1192\/bjp.154.3.348","article-title":"Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study","volume":"154","author":"Gossop","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002024.pub5-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002021.pub3","article-title":"Opioid antagonists with minimal sedation for opioid withdrawal","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD002024.pub5-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002025.pub4","article-title":"Buprenorphine for the management of opioid withdrawal","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002022.pub3","article-title":"Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal","author":"Gowing","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD002024.pub5-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/add.12899","article-title":"Global statistics on addictive behaviours: 2014 status report","volume":"110","author":"Gowing","year":"2015","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0094|cit94","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD002024.pub5-BIB0095|cit95","first-page":"30","article-title":"The treatment of narcotic withdrawal: a historical review","volume":"43","author":"Kleber","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1300\/J251v02n01_03","article-title":"Detoxification from heroin dependency: an overview of method and effectiveness","volume":"2","author":"Lipton","year":"1983","journal-title":"Advances in Alcohol and Substance Abuse"},{"issue":"2","key":"10.1002\/14651858.CD002024.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(96)90215-9","article-title":"Are detoxification programmes effective?","volume":"347","author":"Mattick","year":"1996","journal-title":"The Lancet"},{"issue":"4","key":"10.1002\/14651858.CD002024.pub5-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006749.pub3","article-title":"Detoxification treatments for opiate dependent adolescents","author":"Minozzi","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.149.2.235","article-title":"The influence of psychological factors on the opiate withdrawal syndrome","volume":"149","author":"Phillips","year":"1986","journal-title":"British Journal of Psychiatry"},{"issue":"6&7","key":"10.1002\/14651858.CD002024.pub5-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/10826088509047756","article-title":"Pharmacological advances in addiction treatment","volume":"20","author":"Preston","year":"1985","journal-title":"International Journal of the Addictions"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0102|cit102","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"5","key":"10.1002\/14651858.CD002024.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/ajp.150.5.695","article-title":"Should protracted withdrawal from drugs be included in DSM-IV?","volume":"150","author":"Satel","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002024.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/14659899909052892","article-title":"Audit of the in-patient management of opioid withdrawal using lofexidine hydrochloride","volume":"4","author":"Sheridan","year":"1999","journal-title":"Journal of Substance Use"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0740-5472(89)90038-X","article-title":"Clonidine transdermal patches for use in outpatient opiate withdrawal","volume":"6","author":"Spencer","year":"1989","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0106|cit106","first-page":"589","article-title":"Management of opioid intoxication and withdrawal","volume-title":"Principles of Addiction Medicine","author":"Tetrault","year":"2009"},{"issue":"10","key":"10.1002\/14651858.CD002024.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1360-0443.1988.tb03021.x","article-title":"What can long-term follow-up teach us about relapse and prevention of relapse in addiction?","volume":"83","author":"Vaillant","year":"1988","journal-title":"British Journal of Addiction"},{"key":"10.1002\/14651858.CD002024.pub5-BIB0108|cit108","unstructured":"United Nations Office on Drugs and Crime World Drug Report 2013 www.unodc.org\/unodc\/secured\/wdr\/wdr2013\/World_Drug_Report_2013.pdf"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002024.pub5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T07:27:54Z","timestamp":1715066874000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002024.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,3]]},"references-count":108,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002024.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,3]]}}}